tradingkey.logo

Inspire Medical Systems Inc

INSP
65.700USD
+0.120+0.18%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.91BMarket Cap
43.82P/E TTM

Inspire Medical Systems Inc

65.700
+0.120+0.18%

More Details of Inspire Medical Systems Inc Company

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

Inspire Medical Systems Inc Info

Ticker SymbolINSP
Company nameInspire Medical Systems Inc
IPO dateMay 03, 2018
CEOHerbert (Timothy P)
Number of employees1246
Security typeOrdinary Share
Fiscal year-endMay 03
Address5500 Wayzata Blvd Ste 1600
CityGOLDEN VALLEY
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code55416-1237
Phone17639575037
Websitehttps://www.inspiresleep.com/
Ticker SymbolINSP
IPO dateMay 03, 2018
CEOHerbert (Timothy P)

Company Executives of Inspire Medical Systems Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-294921.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.42K
+181.00%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-4865.00%
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.57K
+200.00%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
+4541.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
-4.00%
Mr. Randall A. (Randy) Ban
Mr. Randall A. (Randy) Ban
Executive Vice President - Patient Access and Therapy Development
Executive Vice President - Patient Access and Therapy Development
--
--
Mr. Richard J. (Rick) Buchholz
Mr. Richard J. (Rick) Buchholz
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dana G. Mead, Jr.
Mr. Dana G. Mead, Jr.
Independent Director
Independent Director
--
--
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-294921.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.42K
+181.00%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-4865.00%
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.57K
+200.00%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
+4541.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
-4.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
214.39M
95.50%
All other countries
10.11M
4.50%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Mon, Feb 2
Updated: Mon, Feb 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.14%
Wellington Management Company, LLP
6.03%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
Other
61.88%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.14%
Wellington Management Company, LLP
6.03%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
Other
61.88%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.18%
Investment Advisor/Hedge Fund
33.26%
Hedge Fund
27.41%
Research Firm
6.21%
Pension Fund
2.17%
Sovereign Wealth Fund
0.96%
Individual Investor
0.87%
Bank and Trust
0.59%
Venture Capital
0.42%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
824
33.76M
116.17%
-6.79M
2025Q3
828
32.29M
111.12%
-7.29M
2025Q2
883
35.48M
119.97%
-4.91M
2025Q1
912
35.71M
121.08%
-5.66M
2024Q4
874
35.22M
118.69%
-4.72M
2024Q3
852
35.48M
118.45%
-2.86M
2024Q2
825
33.60M
112.73%
-2.85M
2024Q1
801
33.20M
111.87%
-2.01M
2023Q4
786
32.35M
109.45%
+751.92K
2023Q3
753
29.93M
101.80%
-635.63K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
3.19M
10.97%
-303.16K
-8.69%
Sep 30, 2025
The Vanguard Group, Inc.
2.99M
10.3%
-203.50K
-6.37%
Sep 30, 2025
Citadel Advisors LLC
1.71M
5.9%
-35.37K
-2.02%
Oct 06, 2025
Deerfield Management Company, L.P.
1.48M
5.08%
+428.61K
+40.91%
Nov 06, 2025
William Blair Investment Management, LLC
1.30M
4.47%
+528.40K
+68.70%
Sep 30, 2025
State Street Investment Management (US)
979.31K
3.37%
-51.59K
-5.00%
Sep 30, 2025
Braidwell LP
883.75K
3.04%
+361.34K
+69.17%
Sep 30, 2025
Soleus Capital Management, L.P.
728.19K
2.51%
+619.19K
+568.06%
Sep 30, 2025
Janus Henderson Investors
667.08K
2.3%
+26.16K
+4.08%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
2.68%
State Street SPDR S&P Health Care Equipment ETF
1.63%
Invesco S&P SmallCap Health Care ETF
1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
0.53%
iShares S&P Small-Cap 600 Growth ETF
0.43%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
0.27%
WisdomTree US SmallCap Quality Growth Fund
0.26%
View more
Global X HealthTech ETF
Proportion2.68%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.63%
Invesco S&P SmallCap Health Care ETF
Proportion1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.53%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.43%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proportion0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.27%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.26%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI